Production Information Management
PIM (Product Information Management) is a centralized software tool that stores, standardizes, an ... Read More
Q fever is a mild disease with flu-like symptoms. Many patients have no symptoms at all while in some cases; the infection can reoccur/resurface years later. The chronic Q fever is a more deadly form of Q fever which may damage heart, liver, brain, lungs and can cause diabetes in some cases.
The Americas account for the largest share in the global Q fever market owing to the presence of key players in the market and rising emphasis on diagnosis and treatment of rare diseases. Furthermore, the rising awareness about bacterial infection further accelerates the growth of the market. North America is the accounted for the highest market share in this region with the U.S. being the largest market followed by Canada. In the U.S, the prevalence of cardiovascular disease is found to be increasing from last few years. This is attributed to the rising prevalence of chronic diseases such as obesity and diabetes which are major risk factors for cardiovascular diseases.
Market Analysis and Insights: Global Q Fever Market
The global Q Fever market size is projected to reach US$ 5993.9 million by 2027, from US$ 4407.2 million in 2020, at a CAGR of 4.4% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Q Fever market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Q Fever market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Q Fever market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Q Fever market.
Global Q Fever Scope and Market Size
Q Fever market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Q Fever market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Acute Q Fever
Chronic Q Fever
Segment by Application
Hospitals & Clinics
Diagnostic Centers
Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Yashica Pharmaceuticals Private Limited (India)
Merck & Co. (US)
Atox Bio (Israel)
Teva Pharmaceutical Industries (Israel)
Basilea Pharmaceutica Ltd. (Switzerland)
MELINTA THERAPEUTICS(US)
Pfizer (US)
Cipla Inc. (India)
PIM (Product Information Management) is a centralized software tool that stores, standardizes, an ... Read More
Programmatic advertising is growing rapidly and will continue to grow during the forecast period. ... Read More
Proteins are large biomolecules made up of amino acids. They perform number of functions like DNA ... Read More
Pseudotumor Cerebri, also known as idiopathic intracranial hypertension (IIH) is a syndrome of el ... Read More